Tonka
Well-known member
http://diariodigital.sapo.pt/news.asp?section_id=62&id_news=546235
Portuguese-English translation
Tuesday, December 6, 2011 | 11:42
Lower malaria deaths in Africa
Experts warned on Tuesday that despite the decline in malaria deaths in Africa must continue the fight to eradicate the disease, since the variant "Plasmodium vivax" is stable in parts of Asia and Latin America.
A team of specialists from the University of Oxford, led by Peter Gethington, produced a map which shows the impact of this variant, which is not considered as deadly as the "Plasmodium falciparum" - the predominant parasite in Africa - but is the most common in the world. The Malaria Atlas Project (MAP, its acronym in English) was presented at the annual meeting of the American Society of Tropical Medicine and Hygiene (ASTMH) held in the United States, and will be published in the December issue of American Journal of Tropical Medicine and Hygiene. It is estimated that annually about 2,850 million people are at risk of being infected by this variant. India is one of the concentration of the threat, including urban areas like Mumbai, which according to experts debunks the theory that malaria affects only the rural areas. In Latin America, the biggest concern is with a very large area, although sparsely populated, northern Amazonia, mainly affecting Brazil. However, the access point also includes regions of Peru, Colombia and Venezuela. In Central America, Nicaragua is almost entirely an access point vivax malaria, as well as parts of Honduras and Guatemala. By contrast, rates in Africa infection appear to be "very, very low" in most of the continent. However, the map indicates a level 'moderate but stable "in some regions of the Horn of Africa and Madagascar. During the meeting were also presented studies indicating that the existing treatments for vivax malaria are "inadequate" and "potentially toxic" to thousands of people. It's time to take another step "in the struggle against malaria vivax and stop looking at this form of the disease as relatively mild and tolerable," he noted in a statement Peter Hotez, infectious disease specialist and president of the ASTMH.
Portuguese-English translation
Tuesday, December 6, 2011 | 11:42
Lower malaria deaths in Africa
Experts warned on Tuesday that despite the decline in malaria deaths in Africa must continue the fight to eradicate the disease, since the variant "Plasmodium vivax" is stable in parts of Asia and Latin America.
A team of specialists from the University of Oxford, led by Peter Gethington, produced a map which shows the impact of this variant, which is not considered as deadly as the "Plasmodium falciparum" - the predominant parasite in Africa - but is the most common in the world. The Malaria Atlas Project (MAP, its acronym in English) was presented at the annual meeting of the American Society of Tropical Medicine and Hygiene (ASTMH) held in the United States, and will be published in the December issue of American Journal of Tropical Medicine and Hygiene. It is estimated that annually about 2,850 million people are at risk of being infected by this variant. India is one of the concentration of the threat, including urban areas like Mumbai, which according to experts debunks the theory that malaria affects only the rural areas. In Latin America, the biggest concern is with a very large area, although sparsely populated, northern Amazonia, mainly affecting Brazil. However, the access point also includes regions of Peru, Colombia and Venezuela. In Central America, Nicaragua is almost entirely an access point vivax malaria, as well as parts of Honduras and Guatemala. By contrast, rates in Africa infection appear to be "very, very low" in most of the continent. However, the map indicates a level 'moderate but stable "in some regions of the Horn of Africa and Madagascar. During the meeting were also presented studies indicating that the existing treatments for vivax malaria are "inadequate" and "potentially toxic" to thousands of people. It's time to take another step "in the struggle against malaria vivax and stop looking at this form of the disease as relatively mild and tolerable," he noted in a statement Peter Hotez, infectious disease specialist and president of the ASTMH.